ClinicalTrials.govpublic full text
Trial of Pimasertib in Hematological Malignancies
leukemia, myeloid, acute, hematologic neoplasms, mek inhibitor, pimasertib, acute myeloid leukemia, hematological malignancies, elderly patients, phase ii, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 877176
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.